The big earners in a lucrative medical market
Tuesday 19 December 1995
According to John Hodgson, European publishing manager of Bio/technology magazine, some 26 genetically engineered pharmaceuticals have now been licensed for use around the world - 20 of which have been accepted in the UK.
Amgen, the American start-up biotechnology company, has the two top- selling genetically engineered drugs in the US. The company's Neupogen, which is used to stimulate the production of white blood cells following cancer treatment, had US sales of more than $719m last year.
In the rankings of revenue earners, Neupogen is closely followed by Epogen, an Amgen drug to stimulate the production of red blood cells. This generated US revenues of $587m last year. Such drugs are needed to treat cases of serious anaemia, which particularly afflicts people who have to undergo kidney dialysis. Amgen markets Epogen itself, but has an agreement with Ortho-Biotech to market a related red-blood cell stimulating product, known as Procrit, which is worth $500m a year in the US market.
Perhaps the most widely-used drug is human insulin for the treatment of diabetes which, produced by Genentech and marketed by Eli Lilly, has US revenues of around $560m a year. Insulin was one of the first "recombinant DNA" (genetically engineered) drugs to be approved for medicinal use, in 1982. Genentech also produces recombinant human growth hormone which is used to treat pituitary dwarfism and has annual US sales of $217m.
Life & Style blogs
The difference between a psychopath and a sociopath
From criminal to catwalk: Convict Jeremy Meeks wins modelling contract in the most unusual fashion scouting – behind bars
Prostate cancer could actually be five different diseases, say scientists
NHS treatments such as vasectomies and hip operations to be rationed because of cost-cutting
What do the emojis on Snapchat mean?
Yvette Cooper: Our choice is years of Tory rule under Jeremy Corbyn – or a return to a Labour government
Labour leadership contender Jeremy Corbyn says 'we can learn a great deal from Karl Marx'
I am the Jeremy Corbyn supporter that many will tell you doesn't exist
Public anger after French sunbather beaten up by gang for wearing a bikini in Reims park
Labour leadership: New poll shows party is now even 'less electable' than under Ed Miliband
Labour leadership contest: I would never quit the party, says Liz Kendall
- 1 Australia to impose 24-hour curfew on all cats to protect endangered species
- 2 Model's video shoot on the beach interrupted by sudden landing of a group of illegal migrants
- 3 The difference between a psychopath and a sociopath
- 4 MH370: Boeing 777 wing that could match missing plane found on the French island of Reunion
£20000 - £22000 per annum: Recruitment Genius: One of the UK's leading indepen...
£26000 - £35000 per annum: Recruitment Genius: A Systems Administrator is requ...
£27000 - £32000 per annum: Recruitment Genius: This Edinburgh city centre Scho...
£20000 - £25000 per annum + competitive: SThree: SThree are a global FTSE 250...